Literature DB >> 4569819

Thrombophlebitis with diazepam used intravenously.

D E Langdon, J R Harlan, R L Bailey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4569819

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Studies in phlebitis: detection and quantitation using a thermographic camera.

Authors:  G H Ward; P E Nolan; M Chawla; S H Yalkowsky
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

2.  Pulmonary embolus after diazepam sedation.

Authors:  A M Hoare
Journal:  Anesth Prog       Date:  1974-11

3.  Histopathology of veins after intravenous lorazepam and RO 21-3981.

Authors:  R R Pagano; C W Graham; M Galligan; J T Conner; R L Katz
Journal:  Can Anaesth Soc J       Date:  1978-01

4.  Hazards of intra-arterial diazepam.

Authors:  J D Gould; S Lingam
Journal:  Br Med J       Date:  1977-07-30

5.  Upper gastrointestinal endoscopy with and without sedation: patients' opinions.

Authors:  A M Hoare; C F Hawkins
Journal:  Br Med J       Date:  1976-07-03

6.  Sequelae after the intravenous injection of three benzodiazepines--diazepam, lorazepam, and flunitrazepam.

Authors:  J E Hegarty; J W Dundee
Journal:  Br Med J       Date:  1977-11-26

Review 7.  Prevention of venous complications from intravenous anesthesia.

Authors:  J V Johnson
Journal:  Anesth Prog       Date:  1987 Jan-Feb

8.  Acute arterial occlusions due to accidental intra-arterial injections of diazepam.

Authors:  H Rüddel; J K Wang; R E Schmidt; H P Horn; H G Rohner
Journal:  Klin Wochenschr       Date:  1985-01-15

9.  Prospective study of venous complications following intravenous diazepam in dental outpatients.

Authors:  S S Gelfman; R A Dionne; E J Driscoll
Journal:  Anesth Prog       Date:  1981 Sep-Oct

10.  Drug efficacy and side effects following different formulations of intravenous diazepam.

Authors:  M Craig; J F Fielding
Journal:  Ir J Med Sci       Date:  1982-03       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.